kabutan

CellSeed Inc.(7776) Summary

7776
TSE Growth
CellSeed Inc.
248
JPY
-2
(-0.80%)
Dec 15, 3:30 pm JST
1.60
USD
Dec 15, 1:30 am EST
Result
PTS
outside of trading hours
250
Dec 15, 11:28 pm JST
Summary Chart Historical News Financial Result
PER
PBR
6.60
Yield
ー%
Margin Trading Ratio
47,560.00
Stock Price
Dec 15, 2025
Opening Dec 15, 9:00 am
249 JPY 1.59 USD
Previous Close Dec 12
250 JPY 1.60 USD
High Dec 15, 9:16 am
254 JPY 1.62 USD
Low Dec 15, 12:54 pm
246 JPY 1.58 USD
Volume
407,300
Trading Value
0.10B JPY 0.66M USD
VWAP
249.43 JPY 1.61 USD
Minimum Trading Value
24,800 JPY 160 USD
Market Cap
8.60B JPY 0.06B USD
Number of Trades
367
Liquidity & Number of Trades
As of Dec 15, 2025
Liquidity
High
1-Year Average
1,249
1-Year High Mar 27, 2025
29,466
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 0 2,886,500
Nov 28, 2025 0 3,145,700
Nov 21, 2025 26,200 3,590,400 137.04
Nov 14, 2025 0 4,136,500
Nov 7, 2025 0 4,205,100
Company Profile
CellSeed Inc. is a biotech venture originating from Tokyo Women's Medical University, primarily focused on cell sheet regenerative medicine and regenerative medicine support.
Sector
Precision Instruments
CellSeed Inc. is based on cell sheet engineering technology and aims to promote the global adoption of cell sheet regenerative medicine. The company operates in two main areas: regenerative medicine support and cell sheet regenerative medicine. In the regenerative medicine support business, CellSeed Inc. conducts research, development, manufacturing, and sales of temperature-responsive cell culture equipment and related products. The cell sheet regenerative medicine business involves the research, development, manufacturing, and sales of cell sheet regenerative medicine products and their applications.